| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Merck E |
Merck MDMA Patent |
German Patent Office |
1914 |
| Erlenmeyer H, Simon M |
Uber isostere und strukturahnliehe Verbindungen XIII.Zur Kenntnis des ... |
Helvetica Chimica Ac... |
1941 |
| Erlenmeyer H, Simon M |
Uber isostere und strukturahnliehe Verbindungen XIII.Zur Kenntnis des ... |
Helvetica Chimica Ac... |
1941 |
| Erlenmeyer H, Simon M |
Uber isostere und strukturahnliehe Verbindungen XIII.Zur Kenntnis des ... |
Helvetica Chimica Ac... |
1941 |
| Erlenmeyer H, Simon M |
Über isostere und strukturahnliehe Verbindungen XIII.Zur Kenntnis des ... |
Helvetica Chimica Ac... |
1941 |
| Felsinger JMv, Lasagna L,... |
The response of normal men to lysergic acid derivatives (di- and mono-... |
J. Clin. Exper. Psyc... |
1956 |
| Oosterhuis HK |
Influence des médicaments psychotropes sur le métabolism cérébral. Re... |
Acta neurol. belg. |
1961 |
| Ziolko HU |
Persönlichkeitsabhängige Veränderungen in der experimentellen Psychose... |
Arzneimittelforschun... |
1966 |
| Brown JH, Mackey HK, Rigg... |
A novel in vitro assay for anti-inflammatory agents based on stabiliza... |
Abstr. Papers, Amer.... |
1966 |
| Kunge P |
Antisoziale Subkultur durch LSD-abusus? |
Beiheft Medical Trib... |
1967 |
| Löbsack T |
Die unheimlichen Möglichkeiten oder die manipulierte seels |
Düsseldorf, Econ |
1967 |
| Fischer R, Marks PA, Rock... |
Der Einfluss der Struktur der Personlichkeit auf den Ausgang der Model... |
Arzneimittel-Forsch |
1969 |
| Singh MP, Kalia CS, Jain ... |
Chromosomal aberrations induced in barley by LSD |
Science |
1970 |
| Beecher HK |
A physician's response to the psychedelic experience in the death enco... |
Psychedelic Review |
1971 |
| Heimann H |
Psychopharmakologie und Verhalten |
Fortibildungskurse d... |
1971 |
| Hell D, Baumann U, Angst ... |
Drogenkonsum und Persönlichkeit |
Dtsch. med. J. |
1971 |
| Jantz L |
Probleme und Möglochkeiten ambulanter und stationäer Behandlune von Su... |
Therapiewoche |
1976 |
| Kraus L, Stahl E, Thies W... |
Dünnschichtchromatographie von illegalen LSD-Präparaten und die Möglic... |
Schweiz. Apoth.-Ztg |
1977 |
| Kraus L, Stahl E, Thies W... |
Dünnschichtchromatographie von illegalen LSD-Präparaten und die Möglic... |
Planta Med. |
1977 |
| Frischknecht HR, Waser PG |
Actions of Hallucinogens on Ants (Formica Pratensis)-I. Brain Levels o... |
Gen Pharmacol. |
1978 |
| Frischknecht HR, Waser PG |
Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Am... |
Gen.Pharmacol. |
1978 |
| Frischknecht HR, Waser PG |
Actions of Hallucinogens on Ants (Formica Pratensis)-III. Social Behav... |
Gen.Pharmacol. |
1980 |
| Konzett H |
Halluzinogene: LSD, Psilocybin und Mescalin |
Dtsch. Ärztebl. |
1981 |
| Keseberg A |
Drogenabhangigkeit Heranwachsender |
Therapiewoche |
1981 |
| Larson AA, Chinn C, Proud... |
Dual Actions of Lysergic Acid Diethylamide Tartrate (LSD), 2-Bromo-D-L... |
The Journal of Pharm... |
1981 |
| Muggler-Bickel J, Maag F |
Drogen und FŸhrertauglichkeit |
Schweiz Rundschau Me... |
1981 |
| Pietzcker A |
Rauschdrogenmissbrauch und -abhangigkeit |
Psychiatrie fur die ... |
1984 |
| Tashkin DP, Coulson AH, C... |
Respiratory symptoms and lung function in habitual heavy smokers of ma... |
Am Rev Respir Dis |
1987 |
| Kulmala HK, Boja JW, Sche... |
Behavioral suppression following 3,4-methylenenedioxymethamphetamine |
Life Sci |
1987 |
| Francom P, Andrenyak D, L... |
Determination of LSD in urine by capillary column gas chromatography a... |
J Anal Toxicol |
1988 |
| Lim HK, Foltz RL |
In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... |
Chem Res Toxicol |
1988 |
| Dons RF, House JF, Hood D... |
Assessment of desmopressin-enhanced cognitive function in a neurosurgi... |
Mil Med |
1989 |
| Lim HK, Foltz RL |
Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... |
Chem Res Toxicol |
1989 |
| Lim HK, Foltz RL |
In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... |
Biol Mass Spectrom |
1991 |
| Elayan I, Gibb JW, Hanson... |
Long-term alteration in the central monoaminergic systems of the rat b... |
Eur J Pharmacol |
1992 |
| Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
| Lim HK, Zeng S, Foltz RL |
Comparative investigation of disposition of 3,4-(methylenedioxy)metham... |
J Pharm Biomed Anal |
1992 |
| Elayan I, Gibb JW, Hanson... |
Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymet... |
J Pharmacol Exp Ther |
1993 |
| Bohn M, Bohn G, Blaschke ... |
Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... |
Int J Legal Med |
1993 |
| Lim HK, Su Z, Foltz RL |
Stereoselective disposition: enantioselective quantitation of 3,4-(met... |
Biol Mass Spectrom |
1993 |
| Seiden LS, Woolverton WL,... |
Behavioral consequences of partial monoamine depletion in the CNS afte... |
NIDA Res Monogr |
1993 |
| Skop BP, Finkelstein JA, ... |
The serotonin syndrome associated with paroxetine, an over-the-counter... |
Am J Emerg Med |
1994 |
| Kramer HK, Poblete JC, Az... |
3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocati... |
Brain Res |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1996 |
| Ensslin HK, Kovar KA, Mau... |
Toxicological detection of the designer drug 3,4-methylenedioxyethylam... |
J Chromatogr B Biome... |
1996 |
| Frost M, Kohler H, Blasch... |
Analysis of 'Ecstasy' by capillary electrophoresis |
Int J Legal Med |
1996 |
| Spitzer M, Thimm M, Herml... |
Increased activation of indirect semantic associations under psilocybi... |
Biol Psychiatry |
1996 |
| Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
| Ensslin HK, Maurer HH, Go... |
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... |
Drug Metab Dispos |
1997 |
| Gibb JW, Johnson M, Elaya... |
Neurotoxicity of amphetamines and their metabolites |
NIDA Res Monogr |
1997 |
| Matthias P, Tashkin DP, M... |
Effects of varying marijuana potency on deposition of tar and delta9-T... |
Pharmacol Biochem Be... |
1997 |
| Kramer HK, Poblete JC, Az... |
Characterization of the translocation of protein kinase C (PKC) by 3,4... |
Neuropsychopharmacol... |
1998 |
| Fleckenstein AE, Haughey ... |
Differential effects of psychostimulants and related agents on dopamin... |
Eur J Pharmacol |
1999 |
| Chang L, Grob C, Ernst T,... |
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebr... |
Psychiatry Research ... |
2000 |
| Zhang ZF, Morgenstern H, ... |
Marijuana use and increased risk of squamous cell carcinoma of the hea... |
Cancer Epidemiol Bio... |
2000 |
| Yasui N, Kondo T, Furukor... |
Effects of repeated ingestion of grapefruit juice on the single and mu... |
Psychopharmacology (... |
2000 |
| Kraft M, Spahn TW, Menzel... |
[Fulminant liver failure after administration of the herbal antidepres... |
Dtsch Med Wochenschr |
2001 |
| Roth MD, Marques-Magallan... |
Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 ... |
Am J Respir Cell Mol... |
2001 |
| Nordgren HK, Beck O |
Direct screening of urine for MDMA and MDA by liquid chromatography-ta... |
J Anal Toxicol |
2003 |
| Atkins D, Best D, Briss P... |
Grading quality of evidence and strength of recommendations |
BMJ |
2004 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| Hashibe M, Morgenstern H,... |
Marijuana use and the risk of lung and upper aerodigestive tract cance... |
Cancer Epidemiol Bio... |
2006 |
| Maeng S, Zarate CA, Du J,... |
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... |
Biol Psychiatry |
2007 |
| Jager G, de Win MM, Verva... |
Incidental use of ecstasy: no evidence for harmful effects on cognitiv... |
Psychopharmacology (... |
2007 |
| Tashkin DP |
Does smoking marijuana increase the risk of chronic obstructive pulmon... |
CMAJ |
2009 |
| Werse B, Mu&776ller O, un... |
Pilotstudie: Spice, Smoke, Sence & Co. – Cannabinoidhaltige Räuchermis... |
|
2009 |
| Kuchkarov UI, Ashurov ZSh... |
[Efficiency of noophen in heroin addiction] |
Lik Sprava |
2009 |
| Tashkin DP |
Does cannabis use predispose to chronic airflow obstruction? |
Eur Respir J |
2010 |
| Benzenhöfer U, Passie T |
Rediscovering MDMA ecstasy: the role of the American chemist Alexander... |
Addiction |
2010 |
| Casale JF, Hays PA |
Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethyla... |
Microgram Journal |
2012 |
| Tashkin DP |
Effects of marijuana smoking on the lung |
Ann Am Thorac Soc |
2013 |
| Kerr T, Small W, Hyshka E... |
'It's more about the heroin': injection drug users' response to an ove... |
Addiction |
2013 |
| King LA |
New phenethylamines in Europe |
Drug Test Anal |
2014 |
| Huang YH, Zhang ZF, Tashk... |
An epidemiologic review of marijuana and cancer: an update |
Cancer Epidemiol Bio... |
2015 |
| Savage KM, Stough CK, Byr... |
Kava for the treatment of generalised anxiety disorder (K-GAD): study ... |
Trials |
2015 |
| Caldwell HK, Albers HE |
Oxytocin, Vasopressin, and the Motivational Forces that Drive Social B... |
Curr Top Behav Neuro... |
2015 |
| Csete J, Kamarulzaman A, ... |
Public health and international drug policy |
Lancet |
2016 |
| Botticelli MP, Koh HK |
Changing the Language of Addiction |
JAMA |
2016 |
